Literature DB >> 10618060

Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds.

Y Arakawa1, N Shibata, K Shibayama, H Kurokawa, T Yagi, H Fujiwara, M Goto.   

Abstract

A simple disk diffusion test was constructed for detection of IMP-1-type metallo-beta-lactamase-producing gram-negative bacteria. Two Kirby-Bauer disks containing ceftazidime (CAZ) and a filter disk containing a metallo-beta-lactamase inhibitor were used in this test. Several IMP-1 inhibitors such as thiol compounds including 2-mercaptopropionic acid, heavy metal salts, and EDTA were evaluated for this test. Two CAZ disks were placed on a Mueller-Hinton agar plate on which a bacterial suspension was spread according to the method recommended by the National Committee for Clinical Laboratory Standards. The distance between the disks was kept to about 4 to 5 cm, and a filter disk containing a metallo-beta-lactamase inhibitor was placed near one of the CAZ disks within a center-to-center distance of 1.0 to 2.5 cm. For IMP-1-producing strains, the growth-inhibitory zone between the two disks expanded, while no evident change in the shape of the growth-inhibitory zone was observed for CAZ-resistant strains producing serine beta-lactamases such as AmpC or SHV-12. As a result, 2 to 3 microliter of undiluted 2-mercaptopropionic acid or mercaptoacetic acid able to block IMP-1 activity gave the most reproducible and clearest results, and CAZ-resistant strains producing AmpC or extended-spectrum beta-lactamases were distinguishable from IMP-1 producers by this test. A similar observation was made with IMP-1-producing clinical isolates such as Serratia marcescens, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Proteus vulgaris, Pseudomonas aeruginosa, Pseudomonas putida, Acinetobacter spp., and Alcaligenes xylosoxidans. The specificity and sensitivity of this test were comparable to those of PCR analysis using bla(IMP)-specific primers. Therefore, this convenient test would be valuable for daily use in clinical laboratories.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618060      PMCID: PMC86013          DOI: 10.1128/JCM.38.1.40-43.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore.

Authors:  T H Koh; G S Babini; N Woodford; L H Sng; L M Hall; D M Livermore
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

2.  Biochemical properties and purification of metallo-beta-lactamase from Bacteroides fragilis.

Authors:  K Bandoh; Y Muto; K Watanabe; N Katoh; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams.

Authors:  K Senda; Y Arakawa; S Ichiyama; K Nakashima; H Ito; S Ohsuka; K Shimokata; N Kato; M Ohta
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.

Authors:  K Senda; Y Arakawa; K Nakashima; H Ito; S Ichiyama; K Shimokata; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

5.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

6.  Rapid identification of metallo- and serine beta-lactamases.

Authors:  D J Payne; R Cramp; J H Bateson; J Neale; D Knowles
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

7.  Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam.

Authors:  T Horii; Y Arakawa; M Ohta; S Ichiyama; R Wacharotayankun; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.

Authors:  H Ito; Y Arakawa; S Ohsuka; R Wacharotayankun; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

9.  Purification and characterization of metallo-beta-lactamase from Serratia marcescens.

Authors:  K Marumo; A Takeda; Y Nakamura; K Nakaya
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

10.  A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP.

Authors:  Y Arakawa; M Murakami; K Suzuki; H Ito; R Wacharotayankun; S Ohsuka; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  108 in total

1.  Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa.

Authors:  Roberta Migliavacca; Jean-Denis Docquier; Claudia Mugnaioli; Gianfranco Amicosante; Rossana Daturi; Kyungwon Lee; Gian Maria Rossolini; Laura Pagani
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Class 1 integron containing metallo-beta-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan.

Authors:  Jun Yatsuyanagi; Shioko Saito; Seizaburo Harata; Noriyuki Suzuki; Yuko Ito; Ken-Ichi Amano; Katsuhiko Enomoto
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

3.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Clonal spread of IMP-1-producing Pseudomonas aeruginosa in two hospitals in Singapore.

Authors:  Tse Hsien Koh; Grace Chee Yeng Wang; Li-Hwei Sng
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Hsiu-Mei Wu; Shu-Huei Tsai; Chin-Luan Chuang; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

7.  First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.

Authors:  K Lolans; A M Queenan; K Bush; A Sahud; J P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.

Authors:  H Aboufaycal; H S Sader; K Rolston; L M Deshpande; M Toleman; G Bodey; I Raad; R N Jones
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

9.  Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase.

Authors:  Siaw Eng Ho; Geetha Subramaniam; Selvi Palasubramaniam; Parasakthi Navaratnam
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase.

Authors:  Stefan Siemann; Darryl P Evanoff; Laura Marrone; Anthony J Clarke; Thammaiah Viswanatha; Gary I Dmitrienko
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.